Retraction: Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7 (PLoS ONE (2015) 10:5 (e0127682) DOI: 10.1371/journal.pone.0127682);Up-regulation of miR-300 promotes proliferation and invasion of osteosarcoma by targeting BRD7

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Xue, Zhen ^a   Zhao, Jindong ^b   Niu, Liyuan ^c   An, Gang ^a   Guo, Yashan ^a   Ni, Linying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b The Fifth Hospital of Harbin   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 300; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; VIMENTIN; BRD7 PROTEIN, HUMAN; LUCIFERASE; MIRN300 MICRORNA, HUMAN; NONHISTONE PROTEIN; OLIGONUCLEOTIDE;

ARTICLE; BINDING SITE; BRD7 GENE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FETUS; GENE CONTROL; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84942871334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0269904     Document Type: Erratum

References (43)

1. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell proliferation. 2014;47(5):427-34. doi: 10. 1111/cpr.12129 PMID: 25174891
2. Novello C, Pazzaglia L, Cingolani C, Conti A, Quattrini I, Manara MC, et al. miRNA expression profile in human osteosarcoma: role of miR-1 andmiR-133bin proliferation and cell cycle control. International journal of oncology. 2013;42(2):667-75. doi: 10.3892/ijo.2012.1717 PMID: 23229283
3. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PloS one. 2012;7(10):e48086. doi: 10.1371/journal.pone.0048086 PMID: 23133552
4. Thayanithy V, Park C, Sarver AL, Kartha RV, Korpela DM, Graef AJ, et al. Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. PloS one. 2012;7(9):e43720. doi: 10.1371/journal.pone.0043720 PMID: 22957032
5. Hu H, Zhang Y, Cai XH, Huang JF, Cai L. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncology letters. 2012;4(5):1037-42. PMID: 23162647
6. Hasei J, Sasaki T, Tazawa H, Osaki S, Yamakawa Y, Kunisada T, et al. Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells. Molecular cancer therapeutics. 2013;12(3):314-25. doi: 10.1158/1535-7163. MCT-12-0869 PMID: 23315976
7. Li Z, Yu X, Shen J, Wu WK, Chan MT. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell proliferation. 2015;48(1):1-6. doi: 10.1111/cpr.12160 PMID: 25530497
8. Lee JE, Hong EJ, Nam HY, Kim JW, Han BG, Jeon JP. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits. Cell proliferation. 2011;44(1):59-66. doi: 10.1111/j.1365-2184.2010.00717.x PMID: 21199010
9. Li M, Yu M, Liu C, Zhu H, He X, Peng S, et al. miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell proliferation. 2013;46(2):223-31. doi: 10.1111/cpr. 12013 PMID: 23510477
10. Li J, You T, Jing J. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway. Cell proliferation. 2014;47(2):152-60. doi: 10.1111/cpr.12093 PMID: 24517182
11. Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y, et al. DNAmethylation downregulated mir-10bactsasa tumor suppressor in gastric cancer. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2015;18(1):43-54. doi: 10.1007/s10120-014-0340-8 PMID: 24481854
12. Yu X, Li Z. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review). International journal of molecular medicine. 2014;34(4):923-33. doi: 10.3892/ijmm.2014.1853 PMID: 25197940
13. Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X, et al. MicroRNA-10b Promotes Nucleus PulposusCell Proliferation through RhoC-Akt Pathway by Targeting HOXD10in Intervetebral Disc Degeneration. PloSone. 2013;8(12):e83080. doi: 10.1371/journal.pone.0083080 PMID: 24376640
14. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, et al. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget. 2013;4(5):665-76. PMID: 23714687
15. Babae N, Bourajjaj M, Liu Y, Van Beijnum JR, Cerisoli F, Scaria PV, et al. Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma. Oncotarget. 2014;5(16):6687-700. PMID: 25149532
16. Li H, Yang BB. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget. 2012;3(12):1653-68. PMID: 23391506
17. Wang Z, Wang N, Liu P, Chen Q, Situ H, Xie T, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014.
18. Lee HK, Finniss S, Cazacu S, Bucris E, Ziv-Av A, Xiang C, et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. 2013;4(2):346-61. PMID: 23548312
19. Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ, Tang CH. CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget. 2014;5(11):3800-12. PMID: 25003330
20. Ohdaira H, Sekiguchi M, Miyata K, Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell proliferation. 2012;45(1):32-8. doi: 10.1111/j.1365-2184. 2011.00798.x PMID: 22151897
21. Fu LL, Yang Y, Xu HL, Cheng Y, Wen X, Ouyang L, et al. Identification of novel caspase/autophagy-related gene switch to cell fate decisions in breast cancers. Cell proliferation. 2013;46(1):67-75. doi: 10. 1111/cpr.12005 PMID: 23289893
22. Wu Y, Tao Y, Chen Y, Xu W. RhoC regulates the proliferation of gastric cancer cells through interaction with IQGAP1. PloSone. 2012;7(11):e48917. doi: 10.1371/journal.pone.0048917 PMID: 23145020
23. Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, et al. Thetumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PloSone. 2013;8(3):e60155. doi: 10.1371/journal.pone.0060155 PMID: 23544130
24. Luo J, Cai Q, Wang W, Huang H, Zeng H, He W, et al. AmicroRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer. PloSone. 2012;7(6):e40127. doi: 10. 1371/journal.pone.0040127 PMID: 22768238
25. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, et al. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PloSone. 2012;7(11):e51056. doi: 10.1371/journal. pone.0051056 PMID: 23226455
26. Liu G, Jiang C, Li D, Wang R, Wang W. MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014.
27. Chong Y, Zhang J, Guo X, Li G, Zhang S, Li C, et al. MicroRNA-503 acts as a tumor suppressor in osteosarcoma by targeting L1CAM. PloSone. 2014;9(12):e114585. doi: 10.1371/journal.pone.0114585 PMID: 25536034
28. Schirmer U, Doberstein K, Rupp AK, Bretz NP, Wuttig D, Kiefel H, et al. Role of miR-34aasasuppressorof L1CAM in endometrial carcinoma. Oncotarget. 2014;5(2):462-72. PMID: 24497324
29. Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV, et al. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation oftheMDM2/p53 signaling. Oncotarget. 2014;5(19):9106-17. PMID: 25193859
30. Zhang D, Yang G, Chen X, Li C, Wang L, Liu Y, et al. mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells. Journal of molecular neuroscience: MN. 2014;53(4):637-44. doi: 10.1007/s12031-014-0230-x PMID: 24464870
31. Yu J, Xie F, Bao X, Chen W, Xu Q. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Molecular cancer. 2014;13:121. doi: 10.1186/1476-4598-13-121 PMID: 24885626
32. Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ. Molecular characterization of celtix-1, abromodomain protein interacting with the transcription factor interferon regulatory factor 2. Journal of cellular physiology. 2000;185(2):269-79. PMID: 11025449
33. Cuppen E, van Ham M, Pepers B, Wieringa B, Hendriks W. Identification and molecular characterization of BP75, a novel bromodomain-containing protein. FEBS letters. 1999;459(3):291-8. PMID: 10526152
34. Harte MT, O'Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, et al. BRD7, asubunitof SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer research. 2010;70(6):2538-47. doi: 10.1158/0008-5472. CAN-09-2089 PMID: 20215511
35. Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, et al. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. Journal of cellular physiology. 2004;200(1):89-98. PMID: 15137061
36. Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, et al. BRD7 is a candidate tumour suppressor gene required for p53 function. Nature cell biology. 2010;12(4):380-9. doi: 10.1038/ncb2038 PMID: 20228809
37. Zhou M, Xu XJ, Zhou HD, Liu HY, He JJ, Li XL, et al. BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis. Molecular and cellular biochemistry. 2006;292(1-2):205-12. PMID: 17066317
38. Park YA, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, et al. Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014;20(3):565-75. doi: 10.1158/1078-0432. CCR-13-1271 PMID: 24198243
39. Wu WJ, Hu KS, Chen DL, Zeng ZL, Luo HY, Wang F, et al. Prognostic relevance of BRD7 expression in colorectal carcinoma. European journal of clinical investigation. 2013;43(2):131-40. doi: 10.1111/eci.12024 PMID: 23215825
40. Liu H, Zhang L, Niu Z, Zhou M, Peng C, Li X, et al. Promoter methylation inhibits BRD7expression in human nasopharyngeal carcinoma cells. BMC cancer. 2008;8:253. doi: 10.1186/1471-2407-8-253 PMID: 18778484
41. Kikuchi M, Okumura F, Tsukiyama T, Watanabe M, Miyajima N, Tanaka J, et al. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells. Biochimicaetbiophysicaacta. 2009;1793(12):1828-36. doi: 10. 1016/j.bbamcr.2009.11.001 PMID: 19909775
42. Park SW, Herrema H, Salazar M, Cakir I, Cabi S, Basibuyuk Sahin F, et al. BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K. Cell metabolism. 2014;20(1):73-84. doi: 10.1016/j.cmet.2014.04.006 PMID: 24836559
43. Chiu YH, Lee JY, Cantley LC. BRD7, a tumor suppressor, interacts with p85alpha and regulates PI3K activity. Molecular cell. 2014;54(1):193-202. doi: 10.1016/j.molcel.2014.02.016 PMID: 24657164